A clinical research consortium sponsored by NIAID
A research trial for kidney transplant candidates
Participating in RESTARRT
As a participant in RESTARRT, you will receive:
- the experimental medications (ATG and Rituximab) at no cost to you
- regular and frequent monitoring of your health and the health of your transplanted kidney by the RESTARRT team of transplant experts
- the opportunity to gradually reduce and possibly reduce immunosuppressive drugs under close medical supervision
Participation may last up to four and a half years.
Contact the RESTARRT transplant team near you for more information about the study.
Click here to review the benefits and risks of transplant therapy.
